AG0034OE

147-94-4 | 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one

Chemical structure of 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one, CAS 147-94-4
AG0034OE
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 147-94-4
Catalog Number AG0034OE(AGN-PC-0Q12BX)
Chemical Name 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one
EC Number 205-705-9
IUPAC Name 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
InChI InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1
InChI Key UHDGCWIWMRVCDJ-CCXZUQQUSA-N
MDL Number MFCD00066487
Molecular Formula C9H13N3O5
Molecular Weight 243.2166
SMILES O=C1N=C(N)C=CN1[C@H]2[C@H]([C@@H]([C@@H](CO)O2)O)O
UNII 04079A1RDZ
Synonyms
Ara C, Ara-C, Arabinofuranosylcytosine, Arabinoside, Cytosine, Arabinosylcytosine, Aracytidine, Aracytine, beta Ara C, beta-Ara C, Cytarabine, Cytarabine Hydrochloride, Cytonal, Cytosar, Cytosar U, Cytosar-U, Cytosine Arabinoside, cytarabine, 147-94-4, Cytosine arabinoside, Ara-C, Arabinocytidine, Cytosar, Arabinosylcytosine, Cytarabin, Tarabine, Alexan, Udicil, Cytosar-U, 1-beta-D-Arabinofuranosylcytosine, Arabitin, Aracytin, Cytarabina, Arafcyt, Depocyt, Erpalfa, DepoCyte, Arabinofuranosylcytosine, Citarabina, Cytarabinum, Aracytine, Aracytidine, Cytosinearabinoside, Cytarabinoside, Cytosine beta-D-arabinofuranoside, Cytosine-beta-D-arabinofuranoside, Cytonal, beta-D-Arabinosylcytosine, Cytosine arabinofuranoside, Depocyt (liposomal), Cytarabinum [INN-Latin], Citarabina [INN-Spanish], AraC, Cytosine beta-D-arabinoside, Spongocytidine, beta-Ara C, Iretin, Cytosine-1-beta-D-arabinofuranoside, 4-Amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 1beta-D-Arabinosylcytosine, 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone, Cytosine arabinose, 1beta-Arabinofuranasylcytosine, Cytosine 1-beta-D-arabinofuranoside, 1beta-D-Arabinofuranosylcytosine, 1-beta-D-Arabinofaranosylcytosine, Cytosine arabinoside (VAN), beta-Arabinosylcytosine, Beta-cytosine arabinoside, Cytosine-beta-arabinoside, CHX 3311, 1-Arabinofuranosylcytosine, 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, cytarabine liposome injection, 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one, Cytosine, beta-D-arabinoside, CCRIS 913, 1-beta-D-Arabinosylcytosine, UNII-04079A1RDZ, Arabinoside C, Cytosine, 1-beta-D-arabinosyl-, HSDB 3049, (beta-D-Arabinofuranosyl)cytosine, EINECS 205-705-9, MFCD00066487, Cytosine, 1-beta-D-arabinofuranosyl-, CHEMBL803, NSC 287459, U 19920A, 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin, AI3-52329, 2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-, AR3, 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech], C9H13N3O5, CHEBI:28680, 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech], UHDGCWIWMRVCDJ-CCXZUQQUSA-N, 04079A1RDZ, 1-beta-D-arabinofuranosyl-cytosine, U-19920, Cytarabine, 98%, 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone, 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside, arabinocytosine, NCGC00093356-03, 2(1H)-Pyrimidinone, 4-amino-1-y-D-arabinofuranosyl- [CAS], NCI-C04728, 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine, DSSTox_CID_2877, AC-1075, U-19,920, 1-(arabinofuranosyl)cytosine, 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one, DSSTox_RID_76771, DSSTox_GSID_22877, 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one, 2(1H)-Pyrimidinone, 4-amino-1-.beta.-D-arabinofuranosyl-, Cytarbel, Ara-Cytidine, Arabinosyl Cytosine, CAS-147-94-4, SMR000449317, Depocyt (TN), Cytarabine [USAN:INN:BAN:JAN], Cytartbine, 1-beta-arabinofuranosylcytosine, SR-01000075773, NSC287459, AK-54744, 1-.beta.-D-arabinofuranosyl-cytosine, 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon, Cytarabine [USAN:USP:INN:BAN:JAN], MK 8242, Cytarabine(Cytosar-U), PubChem14152, beta -arabinosylcytosine, 1-b-D-ribosyl-Cytosine, beta -cytosine arabinoside, Intrathecal cytarabine (also known as ara-C), beta -D-arabinosylcytosine, Cytosine-beta -arabinoside, AC1L1M4F, AC1Q52OJ, SCHEMBL3140, 1-b-D-Ribofuranosylcytosine, 1beta -D-Arabinosylcytosine, BIDD:PXR0139, cytosine-1b-D-Ribofuranoside, Lopac0_000316, KSC917S2P, MLS000758310, MLS001066340, MLS001424023, 1-beta-D-Arabinosyl-Cytosine, 1-beta-delta-ribosyl-Cytosine, BIDD:GT0371, Cytosine, beta -D-arabinoside, Intrathecal (injected into the spinal fluid) DepoCyt, 1beta -Arabinofuranasylcytosine, Cytarabine (JP17/USP/INN), GTPL4827, PYR287, 1-beta-D-ribofuranosyl-Cytosine, cytosine-1b-delta-Ribofuranoside, DTXSID3022877, 1beta-delta-Ribofuranosylcytosine, CTK8B7927, 1beta -D-Arabinofuranosylcytosine, Cytosine, 1-beta -D-arabinosyl-, 1-beta -d-arabinofuranosylcytosine, 1-beta-D-arabinofuranosyl cytosine, 1-beta-delta-Ribofuranosylcytosine, Cytosine-beta -D-arabinofuranoside, HMS2051K19, HMS2090A18, HMS2230M16, HMS3713N12, 1-beta -D-Arabinofaranosylcytosine, cytosine-1beta-delta-Ribofuranoside, 1-beta-delta-ribofuranosyl-Cytosine, BCP02876, CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9), ZINC3795098, Tox21_111203, Tox21_301971, ANW-58969, BDBM50087289, CCG-51297, EBD145460, GP6403, LS-860, s1648, (non-labelled)Cytarabine-13C-15N2, AKOS007930145, AKOS015896896, AM84428, CS-2177, Cytosine, 1-beta -D-arabinofuranosyl-, DB00987, KS-5063, MCULE-3945147956, NC00070, RL01868, KS-0000022L, NCGC00093356-04, NCGC00093356-05, NCGC00093356-06, NCGC00142483-02, NCGC00255381-01, AJ-45634, CPD000449317, HY-13605, SAM001247012, SRI-10828-19, SRI-10828-20, SRI-10828_24, AB0005212, AX8008499, SL-000002, TL8001048, TR-008148, FT-0082880, FT-0624314, ST24043183, SW197450-5, C02961, D00168, J10463, K-4708, 1-BETA-D-ARABINOFURANOSYLCYTOSINE; ARA-C, 10163-EP2272828A1, 10163-EP2284920A1, 10163-EP2287165A2, 10163-EP2287166A2, 10163-EP2292603A1, 10163-EP2292620A2, 10163-EP2298764A1, 10163-EP2298765A1, 10163-EP2298774A1, 10163-EP2299509A1, 10163-EP2301921A1, 10163-EP2301926A1, 10163-EP2301936A1, 10163-EP2308843A1, 10163-EP2314558A1, 10163-EP2316452A1, 10163-EP2371810A1, 10163-EP2372804A1, 10163-EP2378585A1, 15153-EP2270018A1, 15153-EP2272832A1, 15153-EP2275420A1, 15153-EP2277565A2, 15153-EP2277566A2, 15153-EP2277567A1, 15153-EP2277568A2, 15153-EP2277569A2, 15153-EP2277570A2, 15153-EP2277865A1, 15153-EP2292280A1, 15153-EP2295055A2, 15153-EP2295416A2, 15153-EP2295426A1, 15153-EP2295427A1, 15153-EP2298748A2, 15153-EP2298764A1, 15153-EP2298765A1, 15153-EP2298768A1, 15153-EP2298778A1, 15153-EP2298780A1, 15153-EP2301928A1, 15153-EP2305642A2, 15153-EP2305689A1, 15153-EP2308833A2, 15153-EP2308855A1, 15153-EP2308861A1, 15153-EP2311453A1, 15153-EP2311808A1, 15153-EP2311825A1, 15153-EP2311829A1, 15153-EP2311840A1, 15153-EP2311842A2, 15153-EP2314590A1, 15153-EP2316832A1, 15153-EP2316833A1, 15187-EP2270008A1, 15187-EP2280012A2, 15187-EP2281815A1, 15187-EP2292233A2, 15187-EP2292615A1, 15187-EP2292617A1, 15187-EP2301928A1, 15187-EP2301933A1, 15187-EP2305640A2, 15187-EP2305671A1, 15187-EP2308833A2, 15187-EP2311827A1, 15187-EP2311840A1, 15187-EP2316832A1, 15187-EP2316833A1, 147C944, 4-Amino-1-b-D-ribofuranosyl-2(1H)-pyrimidinone, C-55053, SR-01000721860, J-520199, J-700005, J-700166, SR-01000075773-3, SR-01000075773-5, SR-01000721860-6, 1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl, BRD-K33106058-001-07-7, BRD-K33106058-003-20-6, 2(1H)-Pyrimidinone, 4-amino-1-|A-D-arabinofuranosyl-, 2(1H)-Pyrimidinone, 4-amino-1beta -D-arabinofuranosyl-, 4-Amino-1-beta-delta-ribofuranosyl-2(1H)-pyrimidinone, Z1522566619, 2(1H)-Pyrimidinone, 4-amino-1-beta -D-arabinofuranosyl-, Cytarabine, European Pharmacopoeia (EP) Reference Standard, 1-(b-D-Ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine, Cytarabine, United States Pharmacopeia (USP) Reference Standard, Cytarabine; 2(1H)-Pyrimidinone,4-amino-1-a-Darabinofuranosyl-, Cytosine beta-D-arabinofuranoside, crystalline, >=90% (HPLC), 1-(b-delta-Ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine, Cytosine beta-D-arabinofuranoside, Vetec(TM) reagent grade, 90%, Cytarabine, Pharmaceutical Secondary Standard; Certified Reference Material, 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one, cytidine, Cyclocide, Cytarabine HCl, Ara-cell, Cytosine riboside, Cytosar U, beta Ara C, cytarabine liposome, Ara C, Cytosar-U (TN), Arabinoside, Cytosine, Arabinofuranosyl Cytidine, (Arabinofuranosyl)cytosine, 1beta-Ribofuranosylcytosine, D07XSN, CYTARABINE HYDROCHLORIDE, 1beta-D-Ribofuranosylcytosine, cc-278, 1-beta-D-Ribofuranosylcytosine, Cytarabine (JP15/USP/INN), cytosine-1beta-D-Ribofuranoside, CID6253, Cytosine-1-beta-arabinofuranoside, Cytarabine [USAN:BAN:INN:JAN], 1-(beta-d-arabinofuranosyl)cytosine, BTB15125, DRG-0038, NSC63878, C9-H13-N3-O5, ACN-057139, CS-M-34862, Cytosine-1-beta-D-arabinofuranoside hydrochloride, Cytosine beta-D-arabinofuranoside hydrochloride, C2035, Cytosine 1-beta-D-arabinofuranosyl-(6CI8CI), A10265, D003561, Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine, Citosina, 1-.beta.-D-arabinofuranosyl-(6CI, 8CI), 2(1H)-Pirimidinona, 4-amino-1-beta-D-arabinofuranosil-, 2(1H)-Pyrimidinone, 4-amino-1beta-D-arabinofuranosyl-, 4-Amino-1-arabinofuranosyl-2-oxo-1 2-dihydropyrimidine, 2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS], 69-74-9, Cytosine beta-D-arabinofuranoside, 99%, an antimetabolic agent and DNA synthesis inhibitor - 5G 5g,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited